Regulation of PDGF and its receptors in fibrotic diseases

Cytokine and Growth Factor Reviews

Volumn 15, Issue 4, 2004, Pages 255-273

  Bonner, James C ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

connective tissue growth factor; CTGF; FGF; fibroblast growth factor; IL 1 ; interleukin 1 ; PDGF; PDGF receptor ; PDGFR ; PGE 2; platelet derived growth factor; TGF 1; transforming growth factor 1

Indexed keywords

INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ALCOHOL LIVER CIRRHOSIS; AUTOIMMUNITY; CHOLESTASIS; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG INDUCED DISEASE; FIBRIN FORMATION; GENE OVEREXPRESSION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FIBROSIS; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG INJURY; METABOLIC DISORDER; PARACRINE SIGNALING; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN FIBROSIS; TISSUE INJURY; VIRUS HEPATITIS;

EID: 2942682928     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2004.03.006     Document Type: Article

References (185)

1. Heldin C.H., Eriksson U., Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 398:2002;284-290
2. Bonner J.C., Brody A.R. Cytokine-binding proteins in the lung. Am. J. Physiol. 268:1995;L869-L878
3. Schwarz MI, King TE. Interstitial lung disease. Philadelphia, PA: BC Decker Inc.; 1988. 350 p.
4. Martinet Y., Bitterman P.B., Mornex J.F., Grotendorst G.R., Martin G.R., Crystal R.G. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature. 319:1986;158-160
5. Martinet Y., Rom W.N., Grotendorst G.R., Martin G.R., Crystal R.G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:1987;202-209
6. Antoniades H.N., Bravo M.A., Avila R.E., Galanopoulos T., Neville-Golden J., Maxwell M., et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 86:1990;1055-1064
7. Vignaud J.M., Allam M., Martinet N., Pech M., Plenat F., Martinet Y. Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. Am. J. Respir. Cell. Mol. Biol. 5:1991;531-538
8. Homma S., Nagaoka I., Abe H., Takahashi K., Seyama K., Nukiwa T., et al. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Crit. Care Med. 152:1995;2084-2089
9. Nagaoka I., Trapnell B.C., Crystal R.G. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J. Clin. Invest. 85:1990;2023-2027
10. Hertz M.I., Henke C.A., Nakhleh R.E., Harmon K.R., Marinelli W.A., Fox J.M., et al. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10385-10389
11. Bergmann M., Tiroke A., Schafer H., Barth J., Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand. Cardiovasc. J. 32:1998;97-103
12. Harmon K.R., Witkop C.J., White J.G., King R.A., Peterson M., Moore D., et al. Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J. Lab. Clin. Med. 123:1994;617-627
13. Shimokado K., Raines E.W., Madtes D.K., Barrett T.B., Benditt E.P., Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell. 43:1985;277-286
14. Rom W.N., Travis W.D., Brody A.R. Cellular and molecular basis of the asbestos-related diseases. Am. Rev. Respir. Dis. 143:1991;408-422
15. Vanhee D., Gosset P., Wallaert B., Voisin C., Tonnel A.B. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am. J. Respir. Crit. Care Med. 150:1994;1049-1055
16. Fabisiak J.P., Evans J.N., Kelley J. Increased expression of PDGF-B (c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during chronic hyperoxia. Am. J. Respir. Cell. Mol. Biol. 1:1989;181-189
17. Walsh J., Absher M., Kelley J. Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am. J. Respir. Cell. Mol. Biol. 9:1993;637-644
18. Liu J.Y., Morris G.F., Lei W.H., Hart C.E., Lasky J.A., Brody A.R. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. Am. J. Respir. Cell. Mol. Biol. 17:1997;129-140
19. Bonner J.C., Osornio-Vargas A.R., Badgett A., Brody A.R. Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 5:1991;539-547
20. Osornio-Vargas A.R., Bonner J.C., Badgett A., Brody A.R. Rat alveolar macrophage-derived platelet-derived growth factor is chemotactic for rat lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 3:1990;595-602
21. Osornio-Vargas A.R., Goodell A.L., Hernandez-Rodriguez N.A., Brody A.R., Coin P.G., Badgett A., et al. Platelet-derived growth factor (PDGF)-AA, -AB, and -BB induce differential chemotaxis of early-passage rat lung fibroblasts in vitro. Am. J. Respir. Cell. Mol. Biol. 12:1995;33-40
22. Lasky J.A., Coin P.G., Lindroos P.M., Ostrowski L.E., Brody A.R., Bonner J.C. Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop. Am. J. Respir. Cell. Mol. Biol. 12:1995;162-170
23. Bonner J.C., Goodell A.L., Coin P.G., Brody A.R. Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. J. Clin. Invest. 92:1993;425-430
24. Li X., Ponten A., Aase K., Karlsson L., Abramsson A., Uutela M., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat. Cell Biol. 2:2000;302-309
25. Zhuo Y., Zhang J., Laboy M., Lasky J.A. Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 286:2004;L182-L188
26. Shaw R.J., Benedict S.H., Clark R.A., King T.E. Jr. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am. Rev. Respir. Dis. 143:1991;167-173
27. Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., Stark G.R. Stat1-independent regulation of gene expression in response to IFN-gamma. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6674-6679
28. Raines E.W., Dower S.K., Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 243:1989;393-396
29. Kolb M., Margetts P.J., Anthony D.C., Pitossi F., Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107:2001;1529-1536
30. Ingram J.L., Rice A., Geisenhoffer K., Madtes D.K., Bonner J.C. Interleukin-13 stimulates the proliferation of lung myofibroblasts via a signal transducer and activator of transcription-6-dependent mechanism: a possible mechanism for the development of airway fibrosis in asthma. Chest. 123:2003;422S-424S
31. Bostrom H., Willetts K., Pekny M., Leveen P., Lindahl P., Hedstrand H., et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85:1996;863-873
32. Hoyle G.W., Li J., Finkelstein J.B., Eisenberg T., Liu J.Y., Lasky J.A., et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am. J. Pathol. 154:1999;1763-1775
33. Yoshida M., Sakuma J., Hayashi S., Abe K., Saito I., Harada S., et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9570-9574
34. Yi E.S., Lee H., Yin S., Piguet P., Sarosi I., Kaufmann S., et al. Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am. J. Pathol. 149:1996;539-548
35. Bonner J.C., Lindroos P.M., Rice A.B., Moomaw C.R., Morgan D.L. Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo. Am. J. Physiol. 274:1998;L72-L80
36. Lasky J.A., Tonthat B., Liu J.Y., Friedman M., Brody A.R. Upregulation of the PDGF-alpha receptor precedes asbestos-induced lung fibrosis in rats. Am. J. Respir. Crit. Care Med. 157:1998;1652-1657
37. Coin P.G., Lindroos P.M., Bird G.S., Osornio-Vargas A.R., Roggli V.L., Bonner J.C. Lipopolysaccharide up-regulates platelet-derived growth factor (PDGF) alpha-receptor expression in rat lung myofibroblasts and enhances response to all PDGF isoforms. J. Immunol. 156:1996;4797-4806
38. Bonner J.C., Rice A.B., Lindroos P.M., O'Brien P.O., Dreher K.L., Rosas I., et al. Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City. Am. J. Respir. Cell. Mol. Biol. 19:1998;672-680
39. Lindroos P.M., Coin P.G., Osornio-Vargas A.R., Bonner J.C. Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts. Am. J. Respir. Cell. Mol. Biol. 13:1995;455-465
40. Lindroos P.M., Coin P.G., Badgett A., Morgan D.L., Bonner J.C. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. Am. J. Respir. Cell. Mol. Biol. 16:1997;283-292
41. Osornio-Vargas A.R., Lindroos P.M., Coin P.G., Badgett A., Hernandez-Rodriguez N.A., Bonner J.C. Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-alpha. Am. J. Physiol. 271:1996;L93-L99
42. Seifert R.A., van Koppen A., Bowen-Pope D.F. PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction. J. Biol. Chem. 268:1993;4473-4480
43. Rupp E., Siegbahn A., Ronnstrand L., Wernstedt C., Claesson-Welsh L., Heldin C.H. A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex. Eur. J. Biochem. 225:1994;29-41
44. Wang Y.Z., Zhang P., Rice A.B., Bonner J.C. Regulation of interleukin-1beta -induced platelet-derived growth factor receptor-alpha expression in rat pulmonary myofibroblasts by p38 mitogen-activated protein kinase. J. Biol. Chem. 275:2000;22550-22557
45. Lindroos P.M., Rice A.B., Wang Y.Z., Bonner J.C. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts. J. Immunol. 161:1998;3464-3468
46. Lindroos P.M., Wang Y.Z., Rice A.B., Bonner J.C. Regulation of PDGFR-alpha in rat pulmonary myofibroblasts by staurosporine. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L354-L362
47. Fukuoka T., Kitami Y., Okura T., Hiwada K. Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer- binding protein-delta in vascular smooth muscle cells. J. Biol. Chem. 274:1999;25576-25582
48. Tsukamoto T., Matsui T., Nakata H., Ito M., Natazuka T., Fukase M., et al. Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation. J. Biol. Chem. 266:1991;10143-10147
49. Yeh Y.L., Kang Y.M., Chaibi M.S., Xie J.F., Graves D.T. IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression. J. Immunol. 150:1993;5625-5632
50. Ohba T., McDonald J.K., Silver R.M., Strange C., LeRoy E.C., Ludwicka A. Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am. J. Respir. Cell. Mol. Biol. 10:1994;405-412
51. Bonner J.C., Badgett A., Lindroos P.M., Coin P.G. Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells. Am. J. Physiol. 271:1996;L880-L888
52. Bonner J.C., Badgett A., Lindroos P.M., Osornio-Vargas A.R. Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro. Am. J. Respir. Cell. Mol. Biol. 13:1995;496-505
53. Boyle J.E., Lindroos P.M., Rice A.B., Zhang L., Zeldin D.C., Bonner J.C. Prostaglandin-E2 counteracts interleukin-1beta-stimulated upregulation of platelet-derived growth factor alpha-receptor on rat pulmonary myofibroblasts. Am. J. Respir. Cell. Mol. Biol. 20:1999;433-440
54. Bonner J.C., Rice A.B., Ingram J.L., Moomaw C.R., Nyska A., Bradbury A., et al. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 161:2002;459-470
55. Reif S., Lang A., Lindquist J.N., Yata Y., Gabele E., Scanga A., et al. The role of focal adhesion kinasephosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J. Biol. Chem. 278:2003;8083-8090
56. Simon A.R., Rai U., Fanburg B.L., Cochran B.H. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275:1998;C1640-C1652
57. Rice A.B., Ingram J.L., Bonner J.C. p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts. Am. J. Respir. Cell. Mol. Biol. 27:2002;759-765
58. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275:2000;2247-2250
59. Friedman S.L. Liver fibrosis - from bench to bedside. J. Hepatol. 38:2003;S38-S53
60. Friedman S.L., Arthur M.J. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J. Clin. Invest. 84:1989;1780-1785
61. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J. Clin. Invest. 84:1989;1786-1793
62. Pinzani M., Gentilini A., Caligiuri A., De Franco R., Pellegrini G., Milani S., et al. Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology. 21:1995;232-239
63. Bissell D.M., Wang S.S., Jarnagin W.R., Roll F.J. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J. Clin. Invest. 96:1995;447-455
64. Wong L., Yamasaki G., Johnson R.J., Friedman S.L. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J. Clin. Invest. 94:1994;1563-1569
65. Pinzani M., Milani S., Herbst H., DeFranco R., Grappone C., Gentilini A., et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am. J. Pathol. 148:1996;785-800
66. Ikura Y., Morimoto H., Ogami M., Jomura H., Ikeoka N., Sakurai M. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J. Gastroenterol. 32:1997;496-501
67. Pinzani M., Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21:2001;397-416
68. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci. 7:2002;d1720-d1726
69. Pages G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8319-8323
70. Marra F., Arrighi M.C., Fazi M., Caligiuri A., Pinzani M., Romanelli R.G., et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology. 30:1999;951-958
71. Marra F., Gentilini A., Pinzani M., Choudhury G.G., Parola M., Herbst H., et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology. 112:1997;1297-1306
72. Carloni V., Pinzani M., Giusti S., Romanelli R.G., Parola M., Bellomo G., et al. Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on ras in human hepatic stellate cells. Hepatology. 31:2000;131-140
73. Carloni V., Defranco R.M., Caligiuri A., Gentilini A., Sciammetta S.C., Baldi E., et al. Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells. Hepatology. 36:2002;582-591
74. Pinzani M., Knauss T.C., Pierce G.F., Hsieh P., Kenney W., Dubyak G.R., et al. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am. J. Physiol. 260:1991;C485-C491
75. Failli P., Ruocco C., De Franco R., Caligiuri A., Gentilini A., Giotti A., et al. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am. J. Physiol. 269:1995;C1133-C1139
76. Mallat A., Gallois C., Tao J., Habib A., Maclouf J., Mavier P., et al. Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J. Biol. Chem. 273:1998;27300-27305
77. Graves L.M., Bornfeldt K.E., Raines E.W., Potts B.C., Macdonald S.G., Ross R., et al. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10300-10304
78. Pinzani M., Marra F., Caligiuri A., DeFranco R., Gentilini A., Failli P., et al. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Br. J. Pharmacol. 119:1996;1117-1124
79. Mallat A., Fouassier L., Preaux A.M., Gal C.S., Raufaste D., Rosenbaum J., et al. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J. Clin. Invest. 96:1995;42-49
80. Paradis V., Dargere D., Bonvoust F., Vidaud M., Segarini P., Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab. Invest. 82:2002;767-774
81. Paradis V., Dargere D., Vidaud M., De Gouville A.C., Huet S., Martinez V., et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology. 30:1999;968-976
82. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107:1996;404-411
83. Harris M.L., Rosen A. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr. Opin. Rheumatol. 15:2003;778-784
84. Medsger Jr TA. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. Philadelphia, PA: Lea & Febiger; 1993. p. 1253-92.
85. Atamas S.P., White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev. 4:2003;537-550
86. LeRoy E.C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J. Clin. Invest. 54:1974;880-889
87. Buckingham R.B., Prince R.K., Rodnan G.P., Taylor F. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J. Lab. Clin. Med. 92:1978;5-21
88. Jelaska A., Korn J.H. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 43:2000;2230-2239
89. Santiago B., Galindo M., Rivero M., Pablos J.L. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts. Arthritis Rheum. 44:2001;1667-1676
90. Gay S., Jones R.E. Jr., Huang G.Q., Gay R.E. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J. Invest. Dermatol. 92:1989;301-303
91. Klareskog L., Gustafsson R., Scheynius A., Hallgren R. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum. 33:1990;1534-1541
92. Pandolfi A., Florita M., Altomare G., Pigatto P., Donati M.B., Poggi A. Increased plasma levels of platelet-derived growth factor activity in patients with progressive systemic sclerosis. Proc. Soc. Exp. Biol. Med. 191:1989;1-4
93. Ludwicka A., Ohba T., Trojanowska M., Yamakage A., Strange C., Smith E.A., et al. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J. Rheumatol. 22:1995;1876-1883
94. Kawaguchi Y. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin. Exp. Immunol. 97:1994;445-450
95. Kawaguchi Y., Hara M., Wright T.M. Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. J. Clin. Invest. 103:1999;1253-1260
96. Takemura H., Suzuki H., Fujisawa H., Yuhara T., Akama T., Yamane K., et al. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. J. Rheumatol. 25:1998;1534-1539
97. Yamakage A., Kikuchi K., Smith E.A., LeRoy E.C., Trojanowska M. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. J. Exp. Med. 175:1992;1227-1234
98. Ichiki Y., Smith E., LeRoy E.C., Trojanowska M. Different effects of basic fibroblast growth factor and transforming growth factor-beta on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts. J. Invest. Dermatol. 104:1995;124-127
99. Kikuchi K., Kadono T., Ihn H., Sato S., Igarashi A., Nakagawa H., et al. Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1. J. Invest. Dermatol. 105:1995;128-132
100. Battegay E.J., Raines E.W., Seifert R.A., Bowen-Pope D.F., Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:1990;515-524
101. Dong C., Zhu S., Wang T., Yoon W., Li Z., Alvarez R.J., et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. PNAS. 99:2002;3908-3913
102. Zhou X., Tan F.K., Reveille J.D., Wallis D., Milewicz D.M., Ahn C., et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum. 46:2002;2990-2999
103. Ostendorf T., Kunter U., Grone H.J., Bahlmann F., Kawachi H., Shimizu F., et al. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 12:2001;909-918
104. Slomowitz L.A. Progression of renal disease. N. Engl. J. Med. 319:1988;1547-1548
105. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., Bowen-Pope D.F. Developmental patterns of PDGF B-chain, PDGF-receptor, and alpha-actin expression in human glomerulogenesis. Kidney Int. 42:1992;390-399
106. Abboud H.E. Role of platelet-derived growth factor in renal injury. Annu. Rev. Physiol. 57:1995;297-309
107. Yoshimura A., Gordon K., Alpers C.E., Floege J., Pritzl P., Ross R., et al. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 40:1991;470-476
108. Floege J., Johnson R.J., Alpers C.E., Fatemi-Nainie S., Richardson C.A., Gordon K., et al. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am. J. Pathol. 142:1993;637-650
109. Floege J., Hudkins K.L., Davis C.L., Schwartz S.M., Alpers C.E. Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J. Am. Soc. Nephrol. 9:1998;211-223
110. Bhandari B., Grandaliano G., Abboud H.E. Platelet-derived growth factor (PDGF) BB homodimer regulates PDGF A- and PDGF B-chain gene transcription in human mesangial cells. Biochem. J. 297:1994;385-388
111. Kohno M., Yasunari K., Minami M., Kano H., Maeda K., Mandal A.K., et al. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. J. Am. Soc. Nephrol. 10:1999;2495-2502
112. Floege J., Eng E., Young B.A., Alpers C.E., Barrett T.B., Bowen-Pope D.F., et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J. Clin. Invest. 92:1993;2952-2962
113. Tang W.W., Ulich T.R., Lacey D.L., Hill D.C., Qi M., Kaufman S.A., et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 148:1996;1169-1180
114. Fraser D., Wakefield L., Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am. J. Pathol. 161:2002;1039-1049
115. Yamabe H., Osawa H., Kaizuka M., Tsunoda S., Shirato K., Tateyama F., et al. Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism. Nephrol. Dial Transplant. 15:2000;872-876
116. Phillips A.O., Steadman R., Topley N., Williams J.D. Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am. J. Pathol. 147:1995;362-374
117. Johnson R.J., Raines E.W., Floege J., Yoshimura A., Pritzl P., Alpers C., et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J. Exp. Med. 175:1992;1413-1416
118. Floege J., Ostendorf T., Janssen U., Burg M., Radeke H.H., Vargeese C., et al. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am. J. Pathol. 154:1999;169-179
119. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1994;1875-1887
120. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8:1994;1888-1896
121. Langham R.G., Kelly D.J., Maguire J., Dowling J.P., Gilbert R.E., Thomson N.M. Over-expression of platelet-derived growth factor in human diabetic nephropathy. Nephrol. Dial Transplant. 18:2003;1392-1396
122. Liapis H., Yu H., Flath A., Steinhardt G.F. Increased expression of platelet-derived growth factor A and collagenous matrix proteins in congenital multicystic renal dysplasia. Nephronology. 76:1997;161-170
123. Ricono J.M., Arar M., Choudhury G.G., Abboud H.E. Effect of platelet-derived growth factor isoforms in rat metanephric mesenchymal cells. Am. J. Physiol. Renal. Physiol. 282:2002;F211-F219
124. Wallmon A., Fellstrom B., Larsson R., Floege J., Topley N., Ljunghall S. PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cells. Exp. Nephrol. 1:1993;238-244
125. Eitner F., Ostendorf T., Van Roeyen C., Kitahara M., Li X., Aase K., et al. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J. Am. Soc. Nephrol. 13:2002;910-917
126. Eitner F., Ostendorf T., Kretzler M., Cohen C.D., Eriksson U., Grone H.J., et al. ERCB-Consortium. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J. Am. Soc. Nephrol. 14:2003;1145-1153
127. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol. 3:2001;512-516
128. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., et al. PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 3:2001;517-521
129. Ostendorf T., van Roeyen C.R., Peterson J.D., Kunter U., Eitner F., Hamad A.J., et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 14:2003;2237-2247
130. Taneda S., Hudkins K.L., Topouzis S., Gilbertson D.G., Ophascharoensuk V., Truong L., et al. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J. Am. Soc. Nephrol. 14:2003;2544-2555
131. Kunz D., Walker G., Eberhardt W., Messmer U.K., Huwiler A., Pfeilschifter J. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. J. Clin. Invest. 100:1997;2800-2809
132. Goppelt-Struebe M., Stroebel M., Hoppe J. Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G/H synthase in mesangial cells. Kidney Int. 50:1996;71-78
133. Hayama M., Inoue R., Akiba S., Sato T. ERK and p38 MAP kinase are involved in arachidonic acid release induced by H(2)O(2) and PDGF in mesangial cells. Am. J. Physiol. Renal. Physiol. 282:2002;F485-F491
134. Huwiler A., Stabel S., Fabbro D., Pfeilschifter J. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem. J. 305:1995;777-784
135. Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4:2002;556-564
136. Choudhury G.G., Grandaliano G., Jin D.C., Katz M.S., Abboud H.E. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Kidney Int. 57:2000;908-917
137. Inaba T., Ishibashi S., Gotoda T., Kawamura M., Morino N., Nojima Y., et al. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes. 45:1996;507-512
138. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., West A.B. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. 277:1999;C183-C201
139. Chowdhury A., Fukuda R., Fukumoto S. Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients. J. Gastroenterol. 31:1996;353-360
140. Leeb S.N., Vogl D., Falk W., Scholmerich J., Rogler G., Gelbmann C.M. Regulation of migration of human colonic myofibroblasts. Growth Factors. 20:2002;81-91
141. Andoh A., Fujino S., Okuno T., Fujiyama Y., Bamba T. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J. Gastroenterol. 37:2002;33-37
142. Karlsson L., Lindahl P., Heath J.K., Betsholtz C. Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development. 127:2000;3457-3466
143. Simm A., Nestler M., Hoppe V. Mitogenic effect of PDGF-AA on cardiac fibroblasts. Basic Res. Cardiol. 93:1998;40-43
144. Shindo T., Manabe I., Fukushima Y., Tobe K., Aizawa K., Miyamoto S., et al. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8:2002;856-863
145. Diez C., Nestler M., Friedrich U., Vieth M., Stolte M., Hu K., et al. Down-regulation of Akt/PKB in senescent cardiac fibroblasts impairs PDGF-induced cell proliferation. Cardiovasc. Res. 49:2001;731-740
146. Ponten A., Li X., Thoren P., Aase K., Sjoblom T., Ostman A., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am. J. Pathol. 163:2003;673-682
147. Reilly J.T. Pathogenesis and management of idiopathic myelofibrosis. Baillieres Clin. Haematol. 11:1998;751-767
148. Caenazzo A., Pietrogrande F., Polato G., Piva E., Masiero M., Sgarabotto D., et al. Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease. Acta Haematol. 81:1989;131-135
149. Martyre M.C., Magdelenat H., Bryckaert M.C., Laine-Bidron C., Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol. 77:1991;80-86
150. Kitagawa M., Yoshida S., Ishige I., Minami J., Kuwata T., Tanizawa T., et al. Immunolocalization of platelet-derived growth factor, transforming growth factor-beta, and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation. Hum. Pathol. 25:1994;723-726
151. Kimura A., Katoh O., Hyodo H., Kuramoto A., Satow Y. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia. Leuk. Lymphoma. 18:1995;237-242
152. Wickenhauser C., Hillienhof A., Jungheim K., Lorenzen J., Ruskowski H., Hansmann M.L., et al. Detection and quantification of transforming growth factor beta (TGF-beta) and platelet-derived growth factor (PDGF) release by normal human megakaryocytes. Leukemia. 9:1995;310-315
153. Katoh O., Kimura A., Itoh T., Kuramoto A. Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am. J. Hematol. 35:1990;145-150
154. Vannucchi A.M., Bianchi L., Cellai C., Paoletti F., Rana R.A., Lorenzini R., et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood. 100:2002;1123-1132
155. Bonner J.C., Hoffman M., Brody A.R. Alpha-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor. Am. J. Respir. Cell. Mol. Biol. 1:1989;171-179
156. Bonner J.C., Goodell A.L., Lasky J.A., Hoffman M.R. Reversible binding of platelet-derived growth factor-AA, -AB, and -BB isoforms to a similar site on the "slow" and "fast" conformations of alpha 2-macroglobulin. J. Biol. Chem. 267:1992;12837-12844
157. Bonner J.C., Osornio-Vargas A.R. Differential binding and regulation of platelet-derived growth factor A and B chain isoforms by alpha 2-macroglobulin. J. Biol. Chem. 270:1995;16236-16242
158. Bonner J.C., Badgett A., Hoffman M., Lindroos P.M. Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha 2-macroglobulin is mediated via an alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism. J. Biol. Chem. 270:1995;6389-6395
159. Gonias S.L., Carmichael A., Mettenburg J.M., Roadcap D.W., Irvin W.P., Webb D.J. Identical or overlapping sequences in the primary structure of human alpha(2)-macroglobulin are responsible for the binding of nerve growth factor-beta, platelet-derived growth factor-BB, and transforming growth factor-beta. J. Biol. Chem. 275:2000;5826-5831
160. Wu S.M., Patel D.D., Pizzo S.V. Oxidized alpha2-macroglobulin (alpha2M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation. J. Immunol. 161:1998;4356-4365
161. Brekken R.A., Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19:2001;816-827
162. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1281-1285
163. Pichler R.H., Hugo C., Shankland S.J., Reed M.J., Bassuk J.A., Andoh T.F., et al. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int. 50:1996;1978-1989
164. Pichler R.H., Bassuk J.A., Hugo C., Reed M.J., Eng E., Gordon K.L., et al. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro. Am. J. Pathol. 148:1996;1153-1167
165. Pollock R.A., Richardson W.D. The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro. Growth Factors. 7:1992;267-277
166. Raines E.W., Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J. Cell Biol. 116:1992;533-543
167. Kelly J.L., Sanchez A., Brown G.S., Chesterman C.N., Sleigh M.J. Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J. Cell Biol. 121:1993;1153-1163
168. Somasundaram R., Schuppan D. Type I, II, IV, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J. Biol. Chem. 271:1996;26884-26891
169. Albanis E., Friedman S.L. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin. Liver Dis. 5:2001;315-334
170. King T.E., Costabel U., Cordier J.R. Idiopathic pulmonary fibrosis: diagnosis and management: international consensus statement. Am. J. Respir. Crit. Care Med. 161:2000;646-664
171. Kraft M., Lewis C., Pham D., Chu H.W. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J. Allergy Clin. Immunol. 107:2001;602-606
172. Haynes A.R., Shaw R.J. Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells. Am. J. Respir. Cell. Mol. Biol. 7:1992;198-206
173. Warshamana G.S., Martinez S., Lasky J.A., Corti M., Brody A.R. Related articles, links free full text dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation. Am. J. Physiol. 274:1998;L499-L507
174. Badgett A., Bonner J.C., Brody A.R. Interferon-gamma modulates lung macrophage production of PDGF-BB and fibroblast growth. J. Lipid Mediat. Cell Signal. 13:1996;89-97
175. Ziesche R., Hofbauer E., Wittmann K., Petkov V., Block L.H. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341:1999;1264-1269
176. Heis-Vahidi-Fard N., Forberg E., Eichinger S., Chott A., Lechner K., Gisslinger H. Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study. Ann. Hematol. 80:2001;79-82
177. Marra F., Choudhury G.G., Abboud H.E. Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis. J. Clin. Invest. 98:1996;1218-1230
178. Toyonaga T., Hino O., Sugai S., Wakasugi S., Abe K., Shichiri M., et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc. Natl. Acad. Sci. U.S.A. 91:1994;614-618
179. Di Sario A., Bendia E., Svegliati Baroni G., Ridolfi F., Casini A., Ceni E., et al. Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J. Hepatol. 37:2002;584-591
180. Gurujeyalakshmi G., Hollinger M.A., Giri S.N. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am. J. Physiol. 276:1999;L311-L318
181. Caligiuri A., De Franco R.M., Romanelli R.G., Gentilini A., Meucci M., Failli P., et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology. 124:2003;504-520
182. Shimizu S., Gabazza E.C., Taguchi O., Yasui H., Taguchi Y., Hayashi T., et al. Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am. J. Respir. Crit. Care Med. 167:2003;1416-1426
183. Rice A.B., Moomaw C.R., Morgan D.L., Bonner J.C. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am. J. Pathol. 155:1999;213-221
184. Savikko J., Taskinen E., Von Willebrand E. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Transplantation. 75:2003;1147-1153
185. Beham-Schmid C., Apfelbeck U., Sill H., Tsybrovsky O., Hofler G., Haas O.A., et al. Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. Blood. 99:2002;381-383